Wikidata

(Q39675983)

English

Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth

scientific article published on January 2011

In more languages

Statements

title
Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
author name string
Alejandro Vazquez-Martin
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
Cristina Oliveras-Ferraros
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
Silvia Cufí
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
Sonia Del Barco
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
Javier A Menendez
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
publication date
1 January 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017
page(s)
52-57
1 reference
stated in
Europe PubMed Central
PubMed ID
20658522
retrieved
13 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39675983&oldid=1854627288"